Skip to content

Administration of Skin Care Products Containing beta-glucan for skin reparing after photodynamic and fractional laser therapies

Administration of Skin Care Products Containing beta-glucan for skin reparing after photodynamic and fractional laser therapies

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031505
Enrollment
Unknown
Registered
2020-04-03
Start date
2019-03-01
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative repair

Interventions

1:topical use of products containing ß-glucan
2:topical use of vehicle

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 44 Years

Inclusion criteria

Inclusion criteria: 1) Patients between 18 and 44 years old who have received photodynamic therapy or CO2 ablative fractional laser therapy or 1565nm non-ablative fractional laser therapy; 2) Fizpatrick skin type III or IV; 3) Agree to participate in this study, follow up on time, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Pregnant women or those who plan to get pregnant during the follow-up period; 2) Prone to scarring; 3) Receiving other clinical studies; 4) Skin diseases with bilateral asymmetry on the face that affect the efficacy evaluation; 5) Received anti-inflammatory drugs such as hormones, epidermal growth factor and other drugs to promote epidermal regeneration on the face within 1 month; 6) Receiving systemic immunosuppressants, antihistamines, hormones and other oral antiallergic and anti-inflammatory drugs; 7) Patients with serious internal diseases, coagulation disorders, psychological and mental diseases, or infectious diseases; 8) Patients with known allergy to lidocaine or any ingredient of the external product.

Design outcomes

Primary

MeasureTime frame
erythema E value;water content;transepidermal water lose;

Secondary

MeasureTime frame
complete scab off time;tolerance;

Countries

China

Contacts

Public ContactXiuli Wang

Shanghai Skin Disease Hospital

xlwang2001@aliyun.com+86 13621642838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026